CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $483,217 | -0.4% | 17,736 | -18.6% | 0.01% | -9.1% |
| Q2 2023 | $485,095 | -23.3% | 21,802 | -25.4% | 0.01% | -26.7% |
| Q1 2023 | $632,624 | -28.7% | 29,207 | -33.1% | 0.02% | -40.0% |
| Q4 2022 | $886,836 | -9.3% | 43,665 | +14.4% | 0.02% | -13.8% |
| Q3 2022 | $978,000 | -13.1% | 38,155 | -19.4% | 0.03% | -19.4% |
| Q2 2022 | $1,125,000 | +1.1% | 47,321 | -4.3% | 0.04% | +5.9% |
| Q1 2022 | $1,113,000 | +15.1% | 49,440 | +1.2% | 0.03% | +9.7% |
| Q4 2021 | $967,000 | +164.9% | 48,846 | +163.1% | 0.03% | +106.7% |
| Q3 2021 | $365,000 | +8.0% | 18,567 | +20.7% | 0.02% | +7.1% |
| Q2 2021 | $338,000 | -15.3% | 15,379 | -8.2% | 0.01% | -22.2% |
| Q1 2021 | $399,000 | -42.6% | 16,752 | -36.9% | 0.02% | -21.7% |
| Q4 2020 | $695,000 | -7.9% | 26,563 | -38.8% | 0.02% | -4.2% |
| Q3 2020 | $755,000 | +54.7% | 43,385 | +49.5% | 0.02% | +60.0% |
| Q2 2020 | $488,000 | -43.3% | 29,011 | -59.9% | 0.02% | -37.5% |
| Q1 2020 | $860,000 | -9.0% | 72,343 | -7.4% | 0.02% | +41.2% |
| Q4 2019 | $945,000 | +38.0% | 78,134 | +61.2% | 0.02% | +41.7% |
| Q3 2019 | $685,000 | -19.3% | 48,460 | -36.4% | 0.01% | -14.3% |
| Q2 2019 | $849,000 | -37.6% | 76,187 | -34.2% | 0.01% | -30.0% |
| Q1 2019 | $1,360,000 | -17.1% | 115,829 | -5.7% | 0.02% | -23.1% |
| Q4 2018 | $1,641,000 | +108.0% | 122,793 | +118.3% | 0.03% | +136.4% |
| Q3 2018 | $789,000 | -28.3% | 56,260 | -19.7% | 0.01% | -31.2% |
| Q2 2018 | $1,101,000 | +222.9% | 70,021 | +238.1% | 0.02% | +220.0% |
| Q1 2018 | $341,000 | +5.9% | 20,712 | +16.1% | 0.01% | 0.0% |
| Q4 2017 | $322,000 | -74.9% | 17,834 | -73.2% | 0.01% | -73.7% |
| Q3 2017 | $1,282,000 | +82.1% | 66,450 | +11.4% | 0.02% | +90.0% |
| Q2 2017 | $704,000 | +450.0% | 59,657 | +410.4% | 0.01% | +400.0% |
| Q1 2017 | $128,000 | -53.6% | 11,689 | -69.2% | 0.00% | -50.0% |
| Q4 2016 | $276,000 | +102.9% | 38,010 | +81.8% | 0.00% | +100.0% |
| Q3 2016 | $136,000 | +65.9% | 20,908 | +39.2% | 0.00% | +100.0% |
| Q2 2016 | $82,000 | -4.7% | 15,024 | -13.4% | 0.00% | 0.0% |
| Q4 2015 | $86,000 | +32.3% | 17,347 | +0.7% | 0.00% | 0.0% |
| Q3 2015 | $65,000 | – | 17,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |